Jeffrey G. Lamothe - 08 Aug 2023 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
EVP, COO
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol
APVO
Transactions as of
08 Aug 2023
Net transactions value
$0
Form type
4
Filing time
10 Aug 2023, 08:41:08 UTC
Previous filing
07 Mar 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APVO Common Stock Options Exercise +11,979 +94% 24,671 08 Aug 2023 Direct F1
transaction APVO Common Stock Options Exercise +1,833 +7.4% 26,504 08 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Options Exercise $0 -11,979 -50% $0.000000 11,979 08 Aug 2023 Common Stock 11,979 Direct F1, F2
transaction APVO Restricted Stock Unit Options Exercise $0 -1,833 -33% $0.000000 3,667 08 Aug 2023 Common Stock 1,833 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
F3 On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023.